Cargando…
Siglec-15 Promotes Evasion of Adaptive Immunity in B-cell Acute Lymphoblastic Leukemia
Siglec-15 (Sig15) has been implicated as an immune checkpoint expressed in solid tumor-infiltrating macrophages and is being targeted in clinical trials with mAbs to normalize the tumor immune microenvironment and stimulate antitumor immunity. However, the role of Sig15 in hematologic malignancies r...
Autores principales: | Pillsbury, Claire E., Dougan, Jodi, Rabe, Jennifer L., Fonseca, Jairo A., Zhou, Chengjing, Evans, Alyssa N., Abukharma, Hasan, Ichoku, Ona, Gonzalez-Flamenco, Gloria, Park, Sunita I., Aljudi, Ahmed, DeRyckere, Deborah, Castellino, Sharon M., Rafiq, Sarwish, Langermann, Solomon, Liu, Linda N., Henry, Curtis J., Porter, Christopher C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351425/ https://www.ncbi.nlm.nih.gov/pubmed/37465593 http://dx.doi.org/10.1158/2767-9764.CRC-23-0056 |
Ejemplares similares
-
Association of race/ethnicity with innate immune tumor microenvironment of children with B-acute lymphoblastic leukemia
por: Gilbert, Julie R, et al.
Publicado: (2022) -
Pediatric T-cell acute lymphoblastic leukemia blast signature and MRD associated immune environment changes defined by single cell transcriptomics analysis
por: Bhasin, Swati S., et al.
Publicado: (2023) -
Development of an Immunohistochemical Assay for Siglec-15
por: Shafi, Saba, et al.
Publicado: (2022) -
Inhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemia
por: Brandao, L N, et al.
Publicado: (2013) -
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
por: Wang, Jun, et al.
Publicado: (2019)